Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -1119.89x is 91% below its 1-year average of -587.01x, near the low end of its 1-year range (-1119.89x–-54.13x).
As of the fiscal period ended Thursday, September 30, 2021. 90.78% below its 12-month average of -587.01x.
Reported quarterly interest coverage; no daily interpolation.
Limited quarterly history available
Interest Coverage needs at least three reported quarters before a meaningful chart is shown.
INTEREST COVERAGE RATIO
-1119.89x
INTEREST COVERAGE RATIO AVG TTM
-587.01x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-90.78%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-17289.58%
vs the sector median at left
Jasper Therapeutics, Inc.
Market Cap
$9.10M
Interest Coverage Ratio
-1119.89x
TTM Avg
-587.01x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.05M
Interest Coverage Ratio
-37.01x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.82M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.71M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.83M
Interest Coverage Ratio
-12.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.86M
Interest Coverage Ratio
-54.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.33M
Interest Coverage Ratio
-17.26x
TTM Avg
23.36x
3Y Avg
23.36x
5Y Avg
23.36x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jasper Therapeutics, Inc. (JSPR) | $9.10M | -1119.89x | -587.01x | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.05M | -37.01x | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.82M | N/A | N/A | N/A | N/A |
| Ainos, Inc. (AIMD)vs › | $9.50M | -19.65x | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | N/A | N/A | N/A | N/A |
| MetaVia Inc. (MTVA)vs › | $9.75M | N/A | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -12.65x | N/A | N/A | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.86M | -54.10x | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.33M | -17.26x | 23.36x | 23.36x | 23.36x |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | -129.91x | N/A | N/A | N/A |
Interest Coverage
-1119.9x
Debt/Equity
0.19
Current Ratio
1.47
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2021-09-30 | -1119.89x |
| 2020-09-30 | -54.13x |
